ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 49 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $60,845,000 | +89.8% | 59,728,000 | +100.9% | 0.06% | +103.4% |
| Q4 2020 | $32,063,000 | +4.0% | 29,728,000 | 0.0% | 0.03% | -9.4% |
| Q3 2020 | $30,827,000 | +2.8% | 29,728,000 | +9.2% | 0.03% | -11.1% |
| Q2 2020 | $29,996,000 | +27.1% | 27,228,000 | +17.7% | 0.04% | -2.7% |
| Q1 2020 | $23,604,000 | +10.6% | 23,128,000 | +24.2% | 0.04% | +54.2% |
| Q4 2019 | $21,338,000 | -29.0% | 18,628,000 | -29.3% | 0.02% | -35.1% |
| Q3 2019 | $30,050,000 | +18.6% | 26,350,000 | +23.4% | 0.04% | +15.6% |
| Q2 2019 | $25,344,000 | +649.2% | 21,350,000 | +754.0% | 0.03% | +700.0% |
| Q1 2019 | $3,383,000 | -67.9% | 2,500,000 | -75.0% | 0.00% | -69.2% |
| Q3 2018 | $10,530,000 | +7.4% | 10,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $9,806,000 | +97.9% | 10,000,000 | +100.0% | 0.01% | +85.7% |
| Q1 2018 | $4,956,000 | -6.2% | 5,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $5,284,000 | -13.4% | 5,000,000 | -16.7% | 0.01% | -30.0% |
| Q4 2016 | $6,105,000 | – | 6,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |